Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele
- PMID: 10912914
- DOI: 10.1007/s004010051186
Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele
Abstract
Amyloid beta protein deposition in cortical and leptomeningeal vessels, causing the most common type of cerebral amyloid angiopathy, is found in sporadic and familial Alzheimer's disease (AD) and is the principal feature in the hereditary cerebral hemorrhage with amyloidosis, Dutch type. The presence of the Apolipopriotein E (APOE)-epsilon4 allele has been implicated as a risk factor for AD and the development of cerebral amyloid angiopathy in AD. We report clinical, pathological and biochemical studies on two APOE-epsilon4 homozygous subjects, who had senile dementia and whose main neuropathological feature was a severe and diffuse amyloid angiopathy associated with perivascular tau neurofibrillary pathology. Amyloid beta protein and ApoE immunoreactivity were observed in leptomeningeal vessels as well as in medium-sized and small vessels and capillaries in the parenchyma of the neocortex, hippocampus, thalamus, cerebellum, midbrain, pons, and medulla. The predominant peptide form of amyloid beta protein was that terminating at residue Val40, as determined by immunohistochemistry, amino acid sequence and mass spectrometry analysis. A crown of tau-immunopositive cell processes was consistently present around blood vessels. DNA sequence analysis of the Amyloid Precursor Protein gene and Presenilin-1 (PS-1) gene revealed no mutations. In these APOE-epsilon4 homozygous patients, the pathological process differed from that typically seen in AD in that they showed a heavy burden of perivascular tau-immunopositive cell processes associated with severe amyloid beta protein angiopathy, neurofibrillary tangles, some cortical Lewy bodies and an absence of neuritic plaques. These cases emphasize the concept that tau deposits may be pathogenetically related to amyloid beta protein deposition.
Similar articles
-
[Expression of apolipoprotein E in Alzheimer's disease and its significance].Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):556-60. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16468304 Chinese.
-
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.Am J Pathol. 1996 Jun;148(6):2083-95. Am J Pathol. 1996. PMID: 8669492 Free PMC article.
-
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.Neuropathol Appl Neurobiol. 2003 Jun;29(3):231-8. doi: 10.1046/j.1365-2990.2003.00457.x. Neuropathol Appl Neurobiol. 2003. PMID: 12787320
-
Biological Signatures of Alzheimer's Disease.Curr Top Med Chem. 2020;20(9):770-781. doi: 10.2174/1568026620666200228095553. Curr Top Med Chem. 2020. PMID: 32108008 Review.
-
Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.Acta Neuropathol Commun. 2023 Dec 19;11(1):205. doi: 10.1186/s40478-023-01681-z. Acta Neuropathol Commun. 2023. PMID: 38115150 Free PMC article. Review.
Cited by
-
Sporadic and familial cerebral amyloid angiopathies.Brain Pathol. 2002 Jul;12(3):343-57. doi: 10.1111/j.1750-3639.2002.tb00449.x. Brain Pathol. 2002. PMID: 12146803 Free PMC article. Review.
-
Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease.Alzheimers Dement (N Y). 2022 Apr 6;8(1):e12285. doi: 10.1002/trc2.12285. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35415209 Free PMC article.
-
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.FASEB J. 2012 May;26(5):1946-59. doi: 10.1096/fj.11-199851. Epub 2012 Jan 17. FASEB J. 2012. PMID: 22253473 Free PMC article.
-
Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy.Acta Neuropathol Commun. 2019 Feb 26;7(1):26. doi: 10.1186/s40478-019-0680-z. Acta Neuropathol Commun. 2019. PMID: 30808415 Free PMC article.
-
The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease.Brain Pathol. 2024 Jan;34(1):e13210. doi: 10.1111/bpa.13210. Epub 2023 Aug 31. Brain Pathol. 2024. PMID: 37652560 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous